| Literature DB >> 27050713 |
Matthew D Morin1, Ying Wang2, Brian T Jones1, Lijing Su3, Murali M R P Surakattula1, Michael Berger4, Hua Huang4, Elliot K Beutler1, Hong Zhang3, Bruce Beutler2, Dale L Boger1.
Abstract
Herein, we report studies leading to the discovery of the neoseptins and a comprehensive examination of the structure-activity relationships (SARs) of this new class of small-molecule mouse Toll-like receptor 4 (mTLR4) agonists. The compounds in this class, which emerged from screening an α-helix mimetic library, stimulate the immune response, act by a well-defined mechanism (mouse TLR4 agonist), are easy to produce and structurally manipulate, exhibit exquisite SARs, are nontoxic, and elicit improved and qualitatively different responses compared to lipopolysaccharide, even though they share the same receptor.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27050713 PMCID: PMC4882283 DOI: 10.1021/acs.jmedchem.6b00177
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446